The epidemiology of sepsis in the United States from 1979 through 2000

New England Journal of Medicine

Volumn 348, Issue 16, 2003, Pages 1546-1554

  Martin, Greg S ^a   Mannino, David M ^b   Eaton, Stephanie ^a   Moss, Marc ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DEMOGRAPHY; FEMALE; FUNGUS; GENDER; GRAM POSITIVE BACTERIUM; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RACE; SEPSIS; UNITED STATES;

CONTINENTAL POPULATION GROUPS; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; SEPSIS; SEX FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 0037451929     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa022139     Document Type: Article

References (45)

1. Chalfin DB, Holbein ME, Fein AM, Carlon GC. Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients. JAMA 1993;269:249-54.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10.
3. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-14.
4. Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990;113:227-42.
5. Hoyert DL, Arias E, Smith BL, Murphy SL, Kochanek KD. Deaths: final data for 1999. National vital statistics reports. Vol. 49. No. 8. Hyattsville, Md.: National Center for Health Statistics, 2001. (DHHS publication no. (PHS) 2001-1120 PRS 01-0573.)
6. Perl TM, Dvorak L, Hwang T, Wenzel RP. Long-term survival and function after suspected gram-negative sepsis. JAMA 1995;274:338-45.
7. Heyland DK, Hopman W, Coo H, Tranmer J, McColl MA. Long-term health-related quality of life in survivors of sepsis: Short Form-36: a valid and reliable measure of health-related quality of life. Crit Care Med 2000;28:3599-605.
8. Adams WL, Yuan Z, Barboriak JJ, Rimm AA. Alcohol-related hospitalizations of elderly people: prevalence and geographic variation in the United States. JAMA 1993;270:1222-5. [Erratum, JAMA 1993;270:2055.]
9. Rubenfeld GD, Angus DC, Pinsky MR, Curtis JR, Connors AF Jr, Bernard GR. Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. Am J Respir Crit Care Med 1999;160:358-67.
10. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
11. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
12. Vincent JL. Dear SIRS, I'm sorry to say that I don't like you. . . . Crit Care Med 1997;25:372-4.
13. Abraham E, Matthay MA, Dinarello CA, et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 2000;28:232-5.
14. Bernard GR, Vincent J-L, Laterre P-F, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
15. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. JAMA 1995;274:968-74.
16. Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28:108-21. [Erratum, Intensive Care Med 2002;28:525-6.]
17. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995;273:117-23.
18. Sands KE, Bates DW, Lanken PN, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997;278:234-40.
19. Increase in National Hospital Discharge Survey rates for septicemia - United States, 1979-1987. MMWR. Morb Mortal Wkly Rep 1990;39:31-4.
20. Kieft H, Hoepelman AI, Zhou W, Rozenberg-Arska M, Struyvenberg A, Verhoef J. The sepsis syndrome in a Dutch university hospital: clinical observations. Arch Intern Med 1993;153:2241-7.
21. Salvo I, de Cian W, Musicco M, et al. The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 1995;21:Suppl 2:S244-S249.
22. Pittet D, Rangel-Frausto S, Li N, et al. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 1995;21:302-9.
23. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000;26:Suppl 1:S64-S74.
24. Bieler GS, Williams RL. Analyzing survey data using SUDAAN release 7.5. Research Triangle Park, N.C.: Research Triangle Institute, 1997.
25. National Hospital Discharge Survey description. Hyattsville, Md.: National Center for Health Statistics, 2002. (Accessed March 25, 2003, at http://www.cdc.gov/nchs/about/major/hdasd/nhdsdes.htm.)
26. Wenzel RP, Edmond MB. Severe sepsis - national estimates. Crit Care Med 2001;29:1472-4.
27. Idem. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 2001;7:174-7.
28. Idem. Managing antibiotic resistance. N Engl J Med 2000;343:1961-3.
29. Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990: National Nosocomial Infections Surveillance System. J Infect Dis 1993;167:1247-51.
30. Bone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992;268:3452-5.
31. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time. Crit Care Med 1998;26:2078-86.
32. Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995;273:306-9.
33. Abel SJ, Finney SJ, Brett SJ, Keogh BF, Morgan CJ, Evans TW. Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax 1998;53:292-4.
34. Angus DC, Birmingham MC, Balk RA, et al. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. JAMA 2000;283:1723-30.
35. Warren BL, Eid A, Singer P, et al. Highdose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001;286:1869-78. [Erratum, JAMA 2002;287:192.]
36. Whittle J, Conigliaro J, Good CB, Lofgren RP. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. N Engl J Med 1993;329:621-7.
37. Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med 2002;347:1585-92.
38. Hubacek JA, Stuber F, Frohlich D, et al. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit Care Med 2001;29:557-61.
39. Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 1996;24:381-4.
40. Mira JP, Cariou A, Grall F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999;282:561-8.
41. Fang XM, Schroder S, Hoeft A, Stuber F. Comparison of two polymorphisms of the inteleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 1999;27:1330-4.
42. Hsia DC, Krushat WM, Fagan AB, Tebbutt JA, Kusserow RP. Accuracy of diagnostic coding for Medicare patients under the prospective-payment system. N Engl J Med 1988;318:352-5. [Erratum, N Engl J Med 1990;322:1540.]
43. Iezzoni LI. Assessing quality using administrative data. Ann Intern Med 1997;127:666-74.
44. Eaton S, Burnham E, Martin GS, Moss M. The ICD-9 code for septicemia maintains a high positive predictive value for clinical sepsis. Am J Respir Crit Care Med 2002;165: A471. abstract.
45. Ollendorf DA, Fendrick AM, Massey K, Williams GR, Oster G. Is sepsis accurately coded on hospital bills? Value Health 2002;5:79-81.